Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy

Clinical trial NCT02723448 · COMPLETED

Trial details

NCT number: NCT02723448
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasculopathy, Retinal, With Cerebral Leukodystrophy Cerebroretinal Vasculopathy, Hereditary

Start date: 2016-12-05
Primary completion: 2020-07-23
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.